Auto parts

aiMotive and Safran collaborate to make ADAS & AD development safer

MOUNTAIN VIEW,Calif.,Dec. 17,2024-- aiMotive,a leading provider of cutting-edge simulation and AI technologies,has joined forces with Safran Electronics & Defense to advance the testing and valid

12-18

Multiplier Taps Industry Leaders from Nium and Paycor to Accelerate Growth

NEW YORK,Dec. 17,2024-- Multiplier,a leading global employment platform,announced today the appointments of Pratik Gandhi as Managing Director and Chief Operating Officer (MD & COO) and Matt Carr

12-18

Hyundai Mobis Tackles Electric Vehicle Battery Overheating with its New Material Technology

SEOUL,South Korea,Dec. 18,2024-- HyundaiMobis (KRX 012330) announced on 18th that it has developed a new battery cell cooling material to prevent battery overheating during ultra-fast charging of ele

12-18

Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients

SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm

12-18

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001

12-18

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis

12-18 Menarini Industrie Farmaceutiche Riunite

2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme

12-18 RemeGen Co., Ltd

Bright Lights, Warm Nights: BLUETTI Portable Power Stations Bring Christmas Delight

Keep the magic of Christmas alive with BLUETTI —powering every moment,wherever the season takes you.

12-18 BLUETTI POWER INC

IBM Study: Vehicles Believed to be Software Defined and AI Powered by 2035

ARMONK,N.Y.,Dec. 13,2024-- The IBM (NYSE: IBM) Institute for Business Value today published its latest \'Automotive 2035\' study which reveals an industry grappling with an erratic transition away fro

12-18 IBM

Remote "One-Key Control" Opens a New Chapter in Smart Substitution

BOLE,China,Dec. 13,2024-- "Device status is normal,and the one-key control operation has been completed." On December 12,the monitoring personnel of the State Grid Bortala Power Supply Compa

12-18 State Grid Bortala Power Supply Company